In a model of myocardial infarction, it was demonstrated that MSCs in hypoxic conditions secrete factors like IL-6, vascular endothelial growth factor (VEGF), and chemokines resulting in enhancing the therapeutic effects of MSCs (49). The gene discussed is IL6; the disease is myocardial infarction.